Sandbox Reserved 1491
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
{{Sandbox_Reserved_ESBS}}<!-- PLEASE ADD YOUR CONTENT BELOW HERE --> | {{Sandbox_Reserved_ESBS}}<!-- PLEASE ADD YOUR CONTENT BELOW HERE --> | ||
| - | ==2xml | + | =='''2xml'''== |
==Preview== | ==Preview== | ||
'''2xml''' is a 2 chain structure. This domain belongs to the [https://en.wikipedia.org/wiki/Human Human] '''KDM4C''' protein. | '''2xml''' is a 2 chain structure. This domain belongs to the [https://en.wikipedia.org/wiki/Human Human] '''KDM4C''' protein. | ||
| - | [https://en.wikipedia.org/wiki/KDM4C KDM4C] is a '''histone demethylase''' involved in the specific demethylation of trimethylated residues (Lys 9 and Lys 36 of histone 3) | + | [https://en.wikipedia.org/wiki/KDM4C KDM4C] is a '''histone demethylase''' involved in the specific demethylation of trimethylated residues (Lys 9 and Lys 36 of histone 3). |
| - | These marks are specific tags for | + | These marks are specific tags for [https://en.wikipedia.org/wiki/Epigenetics epigenetic] activation. |
KDM4C plays a main role in the modification of cell cycle genes expression and thus involved in the growth of [https://en.wikipedia.org/wiki/Cancer_cell tumoral cells]. | KDM4C plays a main role in the modification of cell cycle genes expression and thus involved in the growth of [https://en.wikipedia.org/wiki/Cancer_cell tumoral cells]. | ||
<StructureSection load='2xml' size='340' side='right' caption='Structure of 2xml - monomeric domain of KDM4C' scene=''> | <StructureSection load='2xml' size='340' side='right' caption='Structure of 2xml - monomeric domain of KDM4C' scene=''> | ||
| Line 22: | Line 22: | ||
== Structural highlights == | == Structural highlights == | ||
| - | 2xml is a monomeric domain composed of 348 amino acids. It is made up of two chains A and B. They are asymmetric, i.e. their sequence identities are below 95%. This domain is connected by a | + | 2xml is a [https://en.wikipedia.org/wiki/Protein_domain '''monomeric domain'''] composed of 348 amino acids. It is made up of two '''chains A and B'''. They are asymmetric, i.e. their sequence identities are below 95%. This domain is connected by a [https://en.wikipedia.org/wiki/Beta_hairpin β-hairpin] to the rest of the protein. |
| - | This domain of KDM4C can bind to 5 ligands: Zn2+, Ni2+, N-Oxalylglycine (or OGA), Cl- (interaction only with chain A) and 1,2-ethanediol (or EDO; only with chain A) : | + | This domain of KDM4C can bind to 5 ligands: '''Zn2+''', '''Ni2+''', '''N-Oxalylglycine''' (or OGA), '''Cl-''' (interaction only with chain A) and '''1,2-ethanediol''' (or EDO; only with chain A) : |
| - | OGA: two binding sites (chains A and B). | + | - OGA: two binding sites (chains A and B). |
| - | EDO: three binding sites, only in chain A. They are linked to 2xml by hydrogen bond. | + | - EDO: three binding sites, only in chain A. They are linked to 2xml by hydrogen bond. |
| - | Zn2+: two binding sites (chains A and B). It makes four coordination bonds : with three cysteines and one histidine. | + | - Zn2+: two binding sites (chains A and B). It makes four coordination bonds : with three cysteines and one histidine. |
| - | Ni2+ : two binding sites (chains A and B). It makes five coordination bonds : two with OGA, two with two histidine and a last one with a glutamic acid. | + | - Ni2+ : two binding sites (chains A and B). It makes five coordination bonds : two with OGA, two with two histidine and a last one with a glutamic acid. |
| - | Cl- : one binding site, only in chain A. | + | - Cl- : one binding site, only in chain A. |
| - | 2xml presents, in each of the two chains, parallel β sheets around OGA, forming an hydrophobic (mainly made of aromatic acid) | + | |
| - | The sequence of the domain has been particularly preserved around OGA (when the protein is folded). Thus, the 3D structure has been very preserved as well, indicating | + | 2xml presents, in each of the two chains, parallel [https://en.wikipedia.org/wiki/Beta_sheet β sheets] around OGA, forming an '''hydrophobic pocket''' (mainly made of aromatic acid). OGA interacts with 2xml amino acids through hydrogen bonds and coordination bonds with Ni2+. |
| + | The sequence of the domain has been particularly preserved around OGA (when the protein is folded)<ref>http://consurf.tau.ac.il/fgij/fg.htm?mol=/temp/2XMLA_ConSurf_DB_pipe.pdb </ref>. Thus, the 3D structure has been very preserved as well, indicating that the structure around OGA is essential. | ||
== Epigenetic == | == Epigenetic == | ||
| - | + | Some proteins directly involved in the modification of genes expression without altering changes in the nucleotide sequence. They can modify the chromatin structure by adding (histone acetylase, methylase, phosphorylase) , reading (bromodomain, chromodomain) or removing (histone demethylase, acetylase). | |
| - | + | These epigenetic marks can be defined as features not directly governed by the genetic code including covalent modification of histone proteins. The latter may be tagged with different biochemical groups such as methyl, acetyl or ubiquitin. These groups and their particular pattern of protein modification modify the function of the tagged proteins and influence the way genes are expressed. | |
| + | KDM4C is a histone demethylase which plays a central role in the regulation of histone proteins modifications by removing methyl groups from epigenetic marks. Its actions has directed consequences on gene expression and therefore on heritable phenotype. By removing repressive histone marks (H3K9me3 and H3K36me3) from target genes KDM4C promotes the formation of euchromatin and therefore transcriptional activation. | ||
== Disease == | == Disease == | ||
| - | + | [https://en.wikipedia.org/wiki/Cancer Cancer] is a disease characterized by an abnormally high level of cell proliferation, known as a [https://en.wikipedia.org/wiki/Neoplasm tumor]. This uncontrolled growth is the result of a modification of genetic information and its expression. | |
| - | + | ||
| - | + | ||
| - | + | Cancer cells have several characteristics, related to the activity of KDM4C: | |
| - | KDM4C | + | - Insensitivity to signals that normally regulate cell multiplication (especially antiproliferative signals). |
| - | + | ||
| - | + | - Unlimited cell division | |
| + | |||
| + | - Ability to invade the body and other organs. <ref>Douglas Hanahan et Robert A. Weinberg, « The hallmarks of cancer », Cell, vol. 100, 7 janvier 2000, p. 57-70 (PMID 10647931)</ref> | ||
| + | |||
| + | |||
| + | The development of cancer begins with the modification of the sequence and expression of the genes involved in the [https://en.wikipedia.org/wiki/Cell_cycle cell cycle]. <ref>https://en.wikipedia.org/wiki/Cancer</ref> | ||
| + | The transformation from healthy cells to cancer cells is carried out in two stages: carcinogenesis and tumorigenesis. | ||
| + | During [https://en.wikipedia.org/wiki/Carcinogenesis carcinogenesis], cells accumulate genetic abnormalities, particularly in [https://en.wikipedia.org/wiki/Oncogene oncogenic] sequences. Oncogenes are positive regulators of cell proliferation. After a mutation, they become hyperactive and cause an excessive cellular growth. [https://en.wikipedia.org/wiki/Caretaker_gene Gatekeeper genes] (genes that allow the passage from one stage of the cell cycle to the next) can also be mutated, leading to uncontrolled cell proliferation. | ||
| + | During tumorigenesis, cancer becomes invasive: cancer cells invade other healthy organs. | ||
| + | |||
| + | KDM4C is involved in carcinogenesis as an oncogene. Indeed, by catalyzing the demethylation of H3K9-me3 (lysine 9 from trimethylated histones 3) to H3K9-me2 (lysine 9 from dimethylated histones 3), this protein increases the expression of its target genes. Several KDM4C target genes are involved in cell growth. For example, they influence mitogenic signalling - which promotes mitosis and cell division -, cell cycle regulation and translation. | ||
| + | In cancer cells, KDM4C expression is enhanced. Thus, the growth of tumor cells is greatly increased.3 | ||
| + | In addition, KDM4C is involved in the correct segregation of chromosomes. Its high presence in tumor cells therefore ensures their viability.4 | ||
| + | Finally, KDM4C also plays a role in the tumorigenesis of certain cancers, such as breast cancer, since it allows the proliferation of cancer cells, their migration and their invasive capacity in the triple-negative breast cancer. | ||
For all the implications of KDM4C in different cancers, it is one of the main targets of anti-cancer treatments. | For all the implications of KDM4C in different cancers, it is one of the main targets of anti-cancer treatments. | ||
| - | + | ||
Revision as of 15:05, 10 January 2019
| This Sandbox is Reserved from 06/12/2018, through 30/06/2019 for use in the course "Structural Biology" taught by Bruno Kieffer at the University of Strasbourg, ESBS. This reservation includes Sandbox Reserved 1480 through Sandbox Reserved 1543. |
To get started:
More help: Help:Editing |
2xml
Preview
2xml is a 2 chain structure. This domain belongs to the Human KDM4C protein.
KDM4C is a histone demethylase involved in the specific demethylation of trimethylated residues (Lys 9 and Lys 36 of histone 3). These marks are specific tags for epigenetic activation. KDM4C plays a main role in the modification of cell cycle genes expression and thus involved in the growth of tumoral cells.
| |||||||||||
References
- ↑ http://consurf.tau.ac.il/fgij/fg.htm?mol=/temp/2XMLA_ConSurf_DB_pipe.pdb
- ↑ Douglas Hanahan et Robert A. Weinberg, « The hallmarks of cancer », Cell, vol. 100, 7 janvier 2000, p. 57-70 (PMID 10647931)
- ↑ https://en.wikipedia.org/wiki/Cancer
